Dr. Iosifescu is Director of Clinical Research for the Nathan Kline Institute and Associate Professor of Psychiatry at New York University School of Medicine. His research has led to the validation of novel treatments for patients who have severe mood and anxiety disorders, including pharmacological treatments such as ketamine and other glutamatergic drugs, and devices such as novel forms of magnetic stimulation.
After receiving his medical doctor (M.D.) degree from the Institute of Medicine and Pharmacy in Bucharest, Romania, Dr. Iosifescu completed his internship and psychiatry residency at Harvard Medical School (Massachusetts General Hospital, and McLean Hospital). His research training included a neuroimaging fellowship in the Neuroscience Laboratory at Harvard Medical School, a psychopharmacology fellowship in the MGH Mood and Anxiety Disorders Institute, and a fellowship in the Clinical Investigator Training Program at Harvard and MIT. In parallel Dr. Iosifescu received a Master of Medical Science degree from Harvard University. Until 2010 Dr. Iosifescu was Associate Professor of Psychiatry at Harvard Medical School and Director of Translational Neuroscience in the MGH Depression Clinical and Research Program and MGH Director of the Bipolar Trials Network. And, until March 2017, he was Associate Professor of Psychiatrry at Mount Sinai.
Dr. Iosifescu has authored more than 100 papers in peer-reviewed medical journals, 14 book chapters and more than 100 abstracts. He received a series of prestigious prizes: the NARSAD Young Investigator Award (which he received twice), the Kaplen Award and the Livingston Award from Harvard Medical School, the American Psychiatric Association Young Investigator Award, the NCDEU New Investigator Award, and a National Institute for Mental Health K23 Career Development Award. Dr. Iosifescu was also designated among the “Best Doctors in America” in all editions of “Best Doctors” since 2005.
This person is not in the org chart